Experts on the panel shared many of the same views around SSRIs, arguing that the risks of the drugs during pregnancy are greater than currently accepted.

FDA announced several rulemakings aimed at modernizing its standards of identity (SOIs) for food products – regulations that ...

The FDA and Power Stick recalled thousands of deodorant cases because manufacturing practices did not comply with FDA ...

Cola will be on store shelves, the company announced Tuesday. The news comes several days after President Donald ...

Shipments will halt by close of business Tuesday evening, the company said. Sarepta had initially rejected the agency’s ...

Sarepta Therapeutics is pausing shipments of its gene therapy for muscular dystrophy following several patient deaths that ...

Shares fell 75% to $3.04, putting the stock on track for a record closing low, according to Dow Jones Market Data. The stock ...

US grocers Albertsons, Jewel Osco, Randalls and Tom Thumb issued a multi-state recall on Monday (July 21) for an assortment of tuna products. Per the notices, shared by the US Food and Drug ...

Replimune (REPL) stock slides after as FDA rejects its melanoma drug RP1, boosting shares of Iovance Biotherapeutics (IOVA) which markets a rival drug. Read more here.

The FDA sent letters to companies selling products with concentrated 7-hydroxymitragynine, which is illegal to market.